Efatutazone
Showing 1 - 12 of 12
Liposarcoma Trial in United States (efatutazone)
Active, not recruiting
- Liposarcoma
- efatutazone
-
Little Rock, Arkansas
- +126 more
Aug 16, 2021
Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer Trial in United States (efatutazone, paclitaxel)
Active, not recruiting
- Anaplastic Thyroid Cancer
- Recurrent Thyroid Cancer
- efatutazone
- paclitaxel
-
Anchorage, Alaska
- +252 more
Aug 16, 2021
Advanced Cancer Trial in Washington (CS-7017)
Completed
- Advanced Cancer
-
Washington, District of Columbia(unnamed)
Sep 2, 2020
Advanced NSCLC (NSCLC) Trial in Worldwide (CS-7017, erlotinib)
Completed
- Advanced Non-small Cell Lung Cancer (NSCLC)
-
Denver, Colorado
- +16 more
Jun 12, 2020
Anaplastic Thyroid Cancer Trial in United States (CS-7017, Paclitaxel)
Terminated
- Anaplastic Thyroid Cancer
-
Aurora, Colorado
- +9 more
Aug 31, 2020
NSCLC Trial in Seoul (CS-7017, Erlotinib)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Seoul, Songpa-Gu, Korea, Republic ofAsan Medical Center
Apr 16, 2021
Colorectal Cancer, Tumors, Colorectal Trial in Worldwide (CS7017, irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI))
Completed
- Colorectal Cancer
- Neoplasms, Colorectal
- CS7017
- irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI)
-
Beverly Hills, California
- +17 more
Apr 22, 2020
NSCLC Trial in Seoul (CS-7017, Carboplatin, Paclitaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- CS-7017
- +2 more
-
Seoul, Gangnam-gu, Korea, Republic ofSamsung Medical Center
Jun 23, 2020
Metastatic NSCLC Trial in Worldwide (CS7017 tablets, Paclitaxel, Carboplatin)
Completed
- Metastatic Non-small Cell Lung Cancer
- CS7017 tablets
- +3 more
-
Aurora, Colorado
- +27 more
May 1, 2020
Solid Tumors, Lymphoma, Multiple Myeloma Trial in Washington (CS-7017 and Bexarotene)
Terminated
- Solid Tumors
- +2 more
- CS-7017 and Bexarotene
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Feb 13, 2017